Cargando…
Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis
BACKGROUND: We systematically assessed beneficial and harmful effects of monoclonal antibodies for coronavirus disease 2019 (COVID-19) treatment, and prophylaxis in individuals exposed to severe acute respiratory syndrome coronavirus 2. METHODS: We searched 5 engines and 3 registries until November...
Autores principales: | Hernandez, Adrian V., Piscoya, Alejandro, Pasupuleti, Vinay, Phan, Mi T., Julakanti, Sreya, Khen, Phirin, Roman, Yuani M., Carranza-Tamayo, César O., Escobedo, Angel A., White, C. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307485/ https://www.ncbi.nlm.nih.gov/pubmed/35878688 http://dx.doi.org/10.1016/j.amjmed.2022.06.019 |
Ejemplares similares
-
Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2022) -
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2020) -
Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021) -
Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis
por: Piscoya, Alejandro, et al.
Publicado: (2021) -
Impact of Prophylactic Hydroxychloroquine on People at High Risk of COVID-19: A Systematic Review and Meta-Analysis
por: Hernandez, Adrian V., et al.
Publicado: (2021)